Category: Regulations

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Sequana Medical ,ISIN BE0974340722 on Euronext Brussels will re-open on 10/02/2021 at 9:00 CET. Source: FSMA

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Asit Biotech, ISIN BE0974289218 , on Euronext Brussels is reopened from 10/2/2021 at 09:00 CET following the publication of a press release.   Source: FSMA

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Sequana Medical, ISIN BE0974340722, on Euronext Brussels is suspended on the request of the company from 09/02/2021 at 14:23 CET until the publication of a press release. Source: […]

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Asit Biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 09/2/2021 at 09:00 CET until the publication of a press release.   […]

Home News FCA review finds evidence of growing competition in retail banking Press Releases First published: 20/01/2022 Last updated: 20/01/2022 Greater competition in retail banking is driving choice and lower prices for consumers and small businesses, despite the financial impact of the pandemic. In an update to its 2018 strategic review of retail banking, the […]

Toronto – The Canadian Securities Administrators (CSA) today published a guidance for investment funds on their disclosure practices that relate to environmental, social and governance (ESG) considerations, particularly funds whose investment objectives reference ESG factors and other funds that use ESG strategies (ESG-Related Funds). The guidance is based on existing regulatory requirements and addresses areas […]

Notice Comments Summary FINRA has amended, with immediate effectiveness, the provisions of FINRA Rule 2251 regarding rates of reimbursement for expenses incurred in processing and forwarding proxy and other issuer-related materials.1 As specified in more detail below, the amendments apply the notice and access fees set forth under the rule to the distribution of investment company […]

Washington, DC – The Commodity Futures Trading Commission today announced that the U.S. District Court for the Eastern District of Kentucky entered a consent order for permanent injunction, restitution, and disgorgement against William S. Evans III (d/b/a Turning Point Investments) of Harrodsburg, Kentucky, and Evans’ wife, Frances Evans. The court imposed almost $17 million in […]

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Integrale, ISIN BE0002220862, on Euronext Brussels is suspended on the request of the company from 22/02/2021 at 9:00 CET until the publication of a press release. Source: FSMA

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Acacia Pharma ,ISIN GB00BYWF9Y76, on Euronext Brussels will re-open on 19/02/2021 at 09:00 CET.   Source: FSMA